Disease-Modifying Antirheumatic Drugs Increase Serum Adiponectin Levels in Patients With Rheumatoid Arthritis
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, cilt.17, sa.1, ss.14-17, 2011 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17 Sayı: 1
- Basım Tarihi: 2011
- Doi Numarası: 10.1097/rhu.0b013e318204a587
- Dergi Adı: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.14-17
- Anahtar Kelimeler: adiponectin, acute-phase-response reactants, rheumatoid arthritis, disease activity, INSULIN-RESISTANCE, RISK, LEPTIN
- Eskişehir Osmangazi Üniversitesi Adresli: Evet
Özet
Background: Adiponectin is an adipocyte-derived adipokine with immunosuppressive and anti-inflammatory properties. It also decreases expression of adhesion molecules. In terms of its relationship with acute-phase reactants, there are conflicting results in patients with rheumatoid arthritis (RA).